Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #KZR‐616‐208: A Randomized, Double‐blind, Placebo‐controlled, Phase 2a Study with Open‐label Extension to Evaluate the Safety and Efficacy of Zetomipzomib (KZR‐616) in Patients with Autoimmune Hepatitis
Levitsky, Josh
(PD/PI)
Medicine, Hepatology Division
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
7/18/23
→
7/18/26
Funding
Kezar Life Sciences, Inc.
(Prot #KZR-616-208)
View all
View less